Financial Year |
March 31 2023 |
Monetary Funds |
2,210,855,538.83 |
Held-for-trading Financial Assets |
49,000,000.00 |
Notes Receivable |
179,489,725.91 |
Accounts Receivable |
2,223,390,245.33 |
Advances to Suppliers |
354,995,072.80 |
Other Receivables |
19,467,320.09 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
11,405,833.26 |
Dividend Receivable |
-- |
Inventories |
3,354,841,280.14 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
22,448,092.00 |
Other Current Assets |
823,219,604.76 |
Total Current Assets |
9,558,274,097.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
50,057,131.44 |
Investment Properties |
3,394,484.89 |
Fixed Assetes |
5,011,173,351.20 |
Under-construction Projects |
848,066,397.22 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
440,446,400.19 |
R&D expenses |
1,688,367.00 |
Goodwill |
42,508,736.15 |
Long-Term Deferred and Prepaid Expenses |
5,547,386.35 |
Deferred Income Tax Assets |
81,282,899.75 |
Other Non-Current Assets |
321,544,634.59 |
Sub-Total of Non-Current Assets |
6,805,709,788.78 |
Total Assets |
16,363,983,885.86 |
Short-Term Loans |
4,430,004,604.82 |
Trading Financial liabilities |
-- |
Notes Payable |
783,633,987.36 |
Accounts Payable |
710,445,787.41 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
196,156,140.39 |
Taxes Payable |
37,283,369.68 |
Interest Payable |
3,340,511.55 |
Dividend Payable |
-- |
Other payables |
181,553,468.30 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
322,661,066.78 |
Other Current Liabilities |
611,309,503.39 |
Sub-Total of Current Liabilities |
7,455,210,611.95 |
Long-term Loans |
469,909,070.15 |
Bonds Payable |
1,259,326,746.04 |
Long-Term Accounts Payable |
27,560,080.71 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
91,032,791.73 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,877,526,054.95 |
Total Liabilities |
9,332,736,666.90 |
Paid-In Capital(Or Share Stock) |
3,896,823,104.00 |
Capital Surplus |
1,369,738,081.00 |
Surplus Reserve |
202,434,149.53 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,257,810,383.42 |
Minority Stockholder's Interest |
48,371,123.49 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,982,876,095.47 |
Owner's Equity(Stockholder's Equity) |
7,031,247,218.96 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
16,363,983,885.86 |